KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
KESTRA MEDICAL TECHNOLOGIES, LTD.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$29.37+2.13 (+7.82%)
Close on Oct 19, 2026
- Market cap
- $1.72B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
23 of Kestra Medical Technologies's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jul 31, 2026 | Sep 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 10, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 9, 2026 | Jul 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2026 | Jul 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 10, 2026 | Jul 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2026 | Mar 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Oct 31, 2025 | Dec 11, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 11, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2025 | Dec 4, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 1, 2025 | Dec 1, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2025 | Sep 12, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2025 | Sep 11, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2025 | Sep 4, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 3, 2025 | Jul 22, 2025 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2025 | Jul 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2025 | Jul 15, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2025 | Apr 17, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 7, 2025 | SEC EDGAR |